February 24, 2017: Ohr Pharma will terminate about eight employees following a decision to suspend activities at a lab facility in San Diego, the company announced in a filing with the SEC.
February 24, 2017: Jackie Fouse, president and COO of Celgene will step down from her position on April 1 and remain with the company through June 30.
February 24, 2017: One year ago BioSpace reported that the Bay Area’s Mission Bay, a hotspot for biotech startups, was running out of room.
February 24, 2017: Ouch. Merck took a pre-tax $2.9B hit from its flagging hep C drug candidate uprifosbuvir due to flagging sales in the market, in part due to the success of drugs already available.